tiprankstipranks
TipRanksTop Financial ExpertsInsidersNew Enterprise Associates 13 Lp

New Enterprise Associates 13 Lp Insider Profile

11 Followers
New Enterprise Associates 13 Lp, Ten Percent Owner at Tesaro, holds 3.00M shares in Sagimet Biosciences, Inc. Class A (Ticker: SGMT), holds 34.44M shares in Minerva Surgical (Ticker: UTRS), holds 4.86M shares in Phasebio Pharmaceuticals (Ticker: PHASQ).
tipranks
New Enterprise Associates 13 Lp

New Enterprise Associates 13 Lp
Tesaro (TSRO)
Ten Percent Owner

Ranked #15,161 out of 98,624 Corporate Insiders

Profitable Transactions

41%
7 out of 17 Profitable Transactions

Average Return

+7.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$465M
44.25%
28.25%
19.12%
3.04%
5.34% Others
A breakdown of New Enterprise Associates 13 Lp's holdings

Insider Roles

Cloudflare
(NET)
Ten Percent Owner
Coursera
(COUR)
Ten Percent Owner
Sprout Social
(SPT)
Ten Percent Owner
Minerva Surgical
(UTRS)
Ten Percent Owner
+5 other positions
Roles that New Enterprise Associates 13 Lp holds in companies

Most Profitable Insider Trade

Stock:
Tesaro
(TSRO)
Rating:Informative Buy
Date:Mar 18, 2016 - Mar 18, 2017
Return:+230.40%
The most profitable trade made by New Enterprise Associates 13 Lp

New Enterprise Associates 13 Lp's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TSRO
Tesaro
Jan 22, 2019
Uninformative Sell
726.08M
$0.00
RARX
Ra Pharmaceuticals
Apr 03, 2020
Uninformative Sell
$0.00
Phasebio Pharmaceuticals
Oct 26, 2022
Ten Percent Owner
Informative Sell
249.78K
$116.58K
Cloudflare
Nov 13, 2020
Ten Percent Owner
Uninformative Buy
$205.61M
Sprout Social
Nov 17, 2020
Ten Percent Owner
Uninformative Sell
$88.85M
Coursera
May 21, 2021
Ten Percent Owner
Uninformative Sell
$131.29M
Minerva Surgical
Feb 10, 2023
Ten Percent Owner
Informative Buy
4.89M
$14.12M
Sagimet Biosciences, Inc. Class A
Jan 31, 2024
Ten Percent Owner
Uninformative Sell
$12.96M
Box
Jan 22, 2015
Ten Percent Owner
Informative Buy
$4.26M
CLVSQ
Clovis Oncology
Jun 05, 2013
Uninformative Sell
$34.20K
~DERM
Dermira
Oct 08, 2014
Uninformative Buy
$65.68M
EPZM
Epizyme
Jan 12, 2016
Informative Buy
10.00M
$9.20M
GlycoMimetics
Jan 15, 2014
Ten Percent Owner
Uninformative Buy
$7.49M
~HIVE
Aerohive Networks
Apr 03, 2014
Uninformative Buy
$20.75M
CRCM
Care
Nov 08, 2017
Uninformative Sell
$33.84M
MM
Millennial Media
Oct 30, 2012
Informative Sell
21.47M
$14.34M
ROKA
Sorrento Tech Inc
Jul 22, 2014
Uninformative Buy
$2.09M
Workday
Apr 11, 2013
Ten Percent Owner
Uninformative Buy
$0.00
OMTH
Omthera
List of latest transactions for each holding click on a transaction to see New Enterprise Associates 13 Lp's performance on stock

New Enterprise Associates 13 Lp insider profile FAQ

What is the percentage of profitable transactions made by New Enterprise Associates 13 Lp?
The percentage of profitable transactions made by New Enterprise Associates 13 Lp is 41%.
    What is the average return per transaction made by New Enterprise Associates 13 Lp?
    The average return per transaction made by New Enterprise Associates 13 Lp is 7.60%.
      What stocks does New Enterprise Associates 13 Lp hold?
      New Enterprise Associates 13 Lp holds: TSRO, RARX, PHASQ, NET, SPT, COUR, UTRS, SGMT, BOX, CLVSQ, ~DERM, EPZM, GLYC, ~HIVE, CRCM, MM, ROKA, WDAY, OMTH stocks.
        What was New Enterprise Associates 13 Lp’s latest transaction?
        New Enterprise Associates 13 Lp latest transaction was an Uninformative Sell of ―.
          What was New Enterprise Associates 13 Lp's most profitable transaction?
          New Enterprise Associates 13 Lp’s most profitable transaction was an Informative Buy of TSRO stock on March 18, 2016. The return on the trade was 230.40%.
            What is New Enterprise Associates 13 Lp's role in Tesaro?
            New Enterprise Associates 13 Lp's role in Tesaro is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.